
SSRI Antidepressant Birth Defect MDL — Cases Against GSK and Pfizer Resume After Pause
The multidistrict litigation (MDL) involving SSRI antidepressant birth defect claims against pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer has...
Read more →

















